Re: A problem in hospitals
- From: Mark Probert <markprobert@xxxxxxxxxxxxxxxx>
- Date: Sat, 12 Aug 2006 11:24:52 -0400
Mark Probert wrote:BrentB wrote:Vernon wrote:Back to that yarn? First, you have yet to show exactly how much theyDon't tell anyone, but, two major, multi-location hospitals are feedingI've heard in Germany some hospitals are using IV ascorbic acid. Very
patients a multi-vitamin tablet every day after the first day.
It MUST be a conspiracy of some sort.
hush hush about it.
Not to mention what are the VA hospitals doing with all that c silver
Second, the evidence that I posted previously (look it up) showed that
they are using it as a topical anti-bacterial. No one disputes that this
is a valid use.
Maybe you can help me. instead of going over old arguments I thought
I'd check out pubmed. Question. If we have a product such as the one
below that stops the epidemic of MRSA why is it not in any mass media
publications or news outlet? An epidemic and a solution yet no one
knows about either...strange, don't you think?
Epidemic? Not exactly.
What makes you believe that there are no silver based dressings?
Antimicrobial and barrier effects of silver against
methicillin-resistant Staphylococcus aureus.
* Edwards-Jones V.
Research Development Unit, St Augustine's, Manchester Metropolitan
University, Manchester, UK. v.e.jones@xxxxxxxxx
OBJECTIVE: Two strains of methicillin-resistant Staphylococcus
aureus (MRSA), termed epidemic strains (EMRSA-15 and EMRSA-16), were
used to evaluate the antimicrobial and barrier effect of four silver
dressings (two silver donating and two non-silver-donating) available
in the UK at the time of the study. METHOD: The moist surface of a
blood agar plate was covered with 10(6) colony-forming units of the
respective strain of MRSA, and dressings were applied to the surface
and incubated at 37 degrees C for different time periods and the upper
and lower surfaces subcultured for residual growth. RESULTS: The
nanocrystalline dressings (silver donating) were effective as a barrier
from one hour until the study end (72 hours): no penetration of
EMRSA-15 and EMRSA-16 through the dressing occurred. Moreover, the
nanocrystalline dressings showed some antimicrobial activity at one
hour in the areas underneath and surrounding the dressing until the
study end. The remaining two dressings had no barrier effect and only
demonstrated limited antimicrobial activity after 24 hours. CONCLUSION:
This in vitro study suggests that the nanocrystalline dressings are
more effective than other silver dressings in terms of providing a
barrier function and antimicrobial activity against EMRSA-15 and
PMID: 16869194 [PubMed - in process]
- Re: A problem in hospitals
- From: BrentB
- Re: A problem in hospitals
- Prev by Date: Re: Seasilver Gets Hit For $120 Million
- Next by Date: Re: A problem in hospitals
- Previous by thread: Re: A problem in hospitals
- Next by thread: Re: A problem in hospitals